Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Duodopa 20 mg/ml + 5 mg/ml intestinal gel

Active Ingredient:
levodopa , carbidopa monohydrate
Company:  
AbbVie Ltd See contact details
ATC code: 
N04BA02
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Duodopa HCP Guide

{healthcare_pro_orange} For Healthcare Professionals

This guide is an educational material as part of the additional risk minimisation program

for Duodopa. This guide is intended to inform gastroenterologists, neurologists and other

healthcare professionals (HCPs) with recommended measures to minimise gastrointestinal,

gastrointestinal device, and gastrointestinal procedure related events.

{pdf_link}

Duodopa Patient guide

This guide is for patients and caregivers of patients who are using Duodopa as a

treatment for advanced Parkinson’s disease (PD).

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

AbbVie Ltd
Company image
Address
AbbVie House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4UB, UK
Telephone
+44 (0)1628 561 090
Medical Information e-mail
[email protected]
WWW
www.abbvie.co.uk
WWW
www.abbviemedinfo.com
Stock Availability
(HCP's only) [email protected]
Medical Information Direct Line
+44 (0)1628 561 092